We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTavistock Regulatory News (TAVI)

Share Price Information for Tavistock (TAVI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.75
Bid: 4.50
Ask: 5.00
Change: 0.00 (0.00%)
Spread: 0.50 (11.111%)
Open: 4.75
High: 4.75
Low: 4.75
Prev. Close: 4.75
TAVI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update And Entry Into Loan Facility

27 Sep 2019 07:00

RNS Number : 8763N
Tavistock Investments PLC
27 September 2019
 

Tavistock Investments Plc

("Tavistock" or the "Company")

Ticker: TAVI

TRADING UPDATE AND ENTRY INTO LOAN FACILITY

 

27  September 2019

 

Trading update

The Board is pleased to report that the Company is trading in line with market expectations, despite challenging market conditions caused by political instability, anxieties over BREXIT outcomes and international trade disputes.

It is impossible to determine how much more challenging conditions may become over the short term and any potential impact on the Company's future trading before more normal conditions return.

The Board continues to believe that it is in the best long-term interests of the Company to improve profitability through:

·; the selective purchases of client books from retiring advisers;

·; investment in initiatives designed to significantly improve inflows of FUM; and

·; reduction of net debt through scheduled capital repayments under its existing NatWest loan facility.

The Company's regulatory capital requirement has increased as a result of these initiatives. However, the Directors' believe that seeking to raise additional capital now would be unduly dilutive for shareholders. To bolster the regulatory capital position in a manner that is not dilutive to shareholders, they have entered into an unsecured convertible loan facility (the "Facility") with two of the Company's directors and its Chief Investment Officer.

The Facility

The Facility is for £630,000 and may be drawn down by the Company at any point within the next year. The Facility is unsecured and is being provided by two of the Company's directors, Oliver Cooke and Brian Raven, and by its Chief Investment Officer, Christopher Peel. Each of them has given an irrevocable undertaking to the Company that upon receipt of 30 days' notice and subject to compliance with regulatory obligations regarding close periods, they will provide up to £210,000 of loan capital to the Company on the following terms:

·; Facility fee 5% of the funds committed;

·; interest payable on funds drawn down of 10%;

·; the repayment of any sums drawn down, together with interest thereon, to be made on 30 September 2020;

·; the option for the Company only, at its absolute discretion, to elect to convert amounts drawn down, together with interest thereon, into new ordinary shares in the Company of 1p each, at a conversion price of 2p per share, being today's bid price; and

·; a non-utilisation fee payable, if appropriate, on 30 September 2020, equivalent to 3% of funds committed but not drawn down.

Related Party Transaction

The entry into the Facility by the Company with Oliver Cooke, Brian Raven and Christopher Peel constitute transactions with related parties under the AIM Rules for Companies. The independent Non-executive Directors of the Company, Roderic Rennison and Peter Dornan, having consulted with the Company's nominated Adviser, Arden Partners, consider that the terms of the transaction are fair and reasonable insofar as the Company's shareholders are concerned.

 

ENQUIRIES

Tavistock Investment plc

Oliver Cooke / Brian Raven +44 (0)1753 867000

Arden Partners plc - Nominated Adviser

Paul Shackleton +44 (0)20 7614 5900

Allenby Capital Limited - Broker

Nick Naylor / Nick Athanas +44 (0)20 3328 5656

Vested - PR Partner

Elspeth Rothwell +44 (0)20 3890 8118

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSEDFUMFUSESU
Date   Source Headline
8th Jan 20247:00 amRNSDirector/PDMR Shareholding
4th Jan 20249:33 amRNSDirector/PDMR Shareholding
19th Dec 20237:00 amRNSInterim Results
1st Nov 202312:25 pmRNSResult of AGM
18th Oct 20234:58 pmRNSNotice of AGM
5th Oct 20237:00 amRNSTrading update and interim dividend declaration
20th Sep 20237:00 amRNSFinal Results for Year Ended 31 March 2023
28th Apr 20235:00 pmRNSTotal Voting Rights
11th Apr 20237:00 amRNSAcquisition of Precise Protect Limited
1st Mar 20237:00 amRNSTotal Voting Rights
16th Feb 20231:45 pmRNSExercise of Options and Total Voting Rights
10th Feb 20237:00 amRNSChange of Auditor
26th Jan 20237:00 amRNSDirector appointment
20th Dec 20227:00 amRNSInterim Results
1st Dec 20227:49 amRNSSale of LEBC Hummingbird Limited
30th Nov 20225:00 pmRNSTotal Voting Rights
22nd Nov 202212:30 pmRNSBuyback shares cancelled
18th Nov 20229:30 amRNSTransaction in Own Shares
4th Nov 202211:30 amRNSExercise of Options and Total Voting Rights
31st Oct 202212:00 pmRNSResult of AGM
6th Oct 20227:00 amRNSNotice of AGM
30th Sep 20225:00 pmRNSTotal Voting Rights
28th Sep 20227:00 amRNSPosting of Annual Report and Accounts
26th Sep 20227:00 amRNSFinal Results for Year Ended 31 March 2022
2nd Sep 202212:49 pmRNSExercise of Options and Total Voting Rights
31st Aug 20225:00 pmRNSTotal Voting Rights
24th Aug 20222:14 pmRNSBuyback shares cancelled
17th Aug 202210:41 amRNSTransaction in Own Shares
16th Aug 202210:14 amRNSDirector/PDMR Shareholding
26th Jul 202211:50 amRNSDirector/PDMR Shareholding
26th Jul 202210:33 amRNSDirector/PDMR Shareholding
12th Jul 20223:42 pmRNSHolding(s) in Company
12th Jul 20221:10 pmRNSHolding(s) in Company
4th Jul 202211:56 amRNSDirector/PDMR Shareholding
30th Jun 20226:29 pmRNSTotal Voting Rights
30th Jun 20222:20 pmRNSDirector/PDMR Shareholding
29th Jun 20222:22 pmRNSDirector/PDMR Shareholding
27th Jun 20227:00 amRNSTrading update and interim dividend declaration
23rd Jun 20222:04 pmRNSExercise of Options and Total Voting Rights
23rd May 20227:00 amRNSAcquisition of LEBC Hummingbird Limited
10th May 20227:00 amRNSDirector/PDMR Shareholding
3rd May 20227:00 amRNSCompletion of purchase of minority holding in LEBC
31st Mar 20225:00 pmRNSTotal Voting Rights
21st Mar 20227:00 amRNSTotal Voting Rights & AIM Rule 17
17th Mar 20227:00 amRNSHolding(s) in Company
28th Feb 202211:06 amRNSSecond Price Monitoring Extn
28th Feb 202211:00 amRNSPrice Monitoring Extension
21st Feb 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Feb 202211:06 amRNSSecond Price Monitoring Extn
11th Feb 202211:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.